Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

被引:381
作者
D'Souza, Anita [1 ,2 ]
Fretham, Caitrin [1 ,3 ]
Lee, Stephanie J. [1 ,4 ,5 ]
Arora, Mukta [1 ,6 ]
Brunner, Janet [1 ]
Chhabra, Saurabh [1 ,2 ]
Devine, Steven [1 ,3 ]
Eapen, Mary [1 ,2 ]
Hamadani, Mehdi [1 ,2 ]
Hari, Parameswaran [1 ,2 ]
Pasquini, Marcelo C. [1 ,2 ]
Perez, Waleska [1 ]
Phelan, Rachel A. [1 ,2 ]
Riches, Marcie L. [1 ,7 ]
Rizzo, J. Douglas [1 ,2 ]
Saber, Wael [1 ,2 ]
Shaw, Bronwen E. [1 ,2 ]
Spellman, Stephen R. [1 ,3 ]
Steinert, Patricia [1 ]
Weisdorf, Daniel J. [1 ]
Horowitz, Mary M. [1 ,2 ]
机构
[1] Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53225 USA
[3] Natl Marrow Donor Program, Minneapolis, MN USA
[4] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Univ Minnesota, Minneapolis, MN USA
[7] Univ N Carolina, Chapel Hill, NC 27515 USA
关键词
Hematopoietic cell transplantation; Activity; Summary slides;
D O I
10.1016/j.bbmt.2020.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hematopoietic cell transplantation (HCT) is a well-established treatment to control and/or cure many malignant and nonmalignant diseases involving the hematopoietic system and some solid tumors. We report information about HCT procedures performed in the United States in 2018 and analyze trends and outcomes of HCT as reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). Overall, compared with 2017, the number of allogeneic HCTs performed in the United States increased by 1%, and the number of autologous HCTs decreased by 5%. Key findings are fewer autologous HCTs performed for non-Hodgkin lymphoma and increasing numbers of haploidentical HCTs, nearly all of which use post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis. There is a continuing increase in HCT in adults age >70 years, particularly for acute myelogenous leukemia and myelodysplastic syndromes. Survival rates by disease, disease stage, donor type, and age are presented. This report, prepared annually by the CIBMTR, provides a snapshot of current transplant activity in the United States. (C) 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
引用
收藏
页码:E177 / E182
页数:6
相关论文
共 7 条
[1]   Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy [J].
Jain, Tania ;
Bar, Merav ;
Kansagra, Ankit J. ;
Chong, Elise A. ;
Hashmi, Shahrukh K. ;
Neelapu, Sattva S. ;
Byrne, Michael ;
Jacoby, Elad ;
Lazaryan, Aleksandr ;
Jacobson, Caron A. ;
Ansell, Stephen M. ;
Awan, Farrukh T. ;
Burns, Linda ;
Bachanova, Veronika ;
Bollard, Catherine M. ;
Carpenter, Paul A. ;
DiPersio, John F. ;
Hamadani, Mehdi ;
Heslop, Helen E. ;
Hill, Joshua A. ;
Komanduri, Krishna, V ;
Kovitz, Craig A. ;
Lazarus, Hillard M. ;
Serrette, Justin M. ;
Mohty, Mohamad ;
Miklos, David ;
Nagler, Arnon ;
Pavletic, Steven Z. ;
Savani, Bipin N. ;
Schuster, Stephen J. ;
Kharfan-Dabaja, Mohamed A. ;
Perales, Miguel-Angel ;
Lin, Yi .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) :2305-2321
[2]   Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy [J].
Kanate, Abraham S. ;
Majhail, Navneet S. ;
Savani, Bipin N. ;
Bredeson, Christopher ;
Champlin, Richard E. ;
Crawford, Stephen ;
Giralt, Sergio A. ;
LeMaistre, Charles F. ;
Marks, David, I ;
Omel, James L. ;
Orchard, Paul J. ;
Palmer, Jeanne ;
Saber, Wael ;
Veys, Paul A. ;
Carpenter, Paul A. ;
Hamadani, Mehdi .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) :1247-1256
[3]   Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States [J].
Muffly, Lori ;
Pasquini, Marcelo C. ;
Martens, Michael ;
Brazauskas, Ruta ;
Zhu, Xiaochun ;
Adekola, Kehinde ;
Aljurf, Mahmoud ;
Ballen, Karen K. ;
Bajel, Ashish ;
Baron, Frederic ;
Battiwalla, Minoo ;
Beitinjaneh, Amer ;
Cahn, Jean-Yves ;
Carabasi, Mathew ;
Chen, Yi-Bin ;
Chhabra, Saurabh ;
Ciurea, Stefan ;
Copelan, Edward ;
D'Souza, Anita ;
Edwards, John ;
Foran, James ;
Freytes, Cesar O. ;
Fung, Henry C. ;
Gale, Robert Peter ;
Giralt, Sergio ;
Hashmi, Shahrukh K. ;
Hildebrandt, Gerhard C. ;
Ho, Vincent ;
Jakubowski, Ann ;
Lazarus, Hillard ;
Luskin, Marlise R. ;
Martino, Rodrigo ;
Maziarz, Richard ;
McCarthy, Philip ;
Nishihori, Taiga ;
Olin, Rebecca ;
Olsson, Richard F. ;
Pawarode, Attaphol ;
Peres, Edward ;
Rezvani, Andrew R. ;
Rizzieri, David ;
Savani, Bipin N. ;
Schouten, Harry C. ;
Sabloff, Mitchell ;
Seftel, Matthew ;
Seo, Sachiko ;
Sorror, Mohamed L. ;
Szer, Jeff ;
Wirk, Baldeep M. ;
Wood, William A. .
BLOOD, 2017, 130 (09) :1156-1164
[4]   Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma [J].
Munshi, Pashna N. ;
Hari, Parameswaran ;
Vesole, David H. ;
Jurczyszyn, Artur ;
Zaucha, Jan ;
Davila, Omar ;
Kumar, Shaji K. ;
Shah, Nina D. ;
Qazilbash, Muzaffar H. ;
D'Souza, Anita .
BLOOD, 2019, 134
[5]  
National Institutes of Health: National Cancer Institute, FDA APPR 2 CAR T CEL
[6]   Hispanics Have the Lowest Stem Cell Transplant Utilization Rate for Autologous Hematopoietic Cell Transplantation for Multiple Myeloma in the United States: A CIBMTR Report [J].
Schriber, Jeffrey R. ;
Hari, Parameswaran N. ;
Ahn, Kwang Woo ;
Fei, Mingwei ;
Costa, Luciano J. ;
Kharfan-Dabaja, Mohamad A. ;
Angel-Diaz, Miguel ;
Gale, Robert P. ;
Ganguly, Siddharatha ;
Girnius, Saulius K. ;
Hashmi, Shahrukh ;
Pawarode, Attaphol ;
Vesole, David H. ;
Wiernik, Peter H. ;
Wirk, Baldeep M. ;
Marks, David I. ;
Nishihori, Taiga ;
Olsson, Richard F. ;
Usmani, Saad Z. ;
Mark, Tomer M. ;
Nieto, Yago L. ;
D'Souza, Anita .
CANCER, 2017, 123 (16) :3141-3149
[7]  
US Food and Drug Administration, FDA APPR AX CIL LARG